The Effect of Toy-Type Nebulizer on Fear and Anxiety in Children Receiving Inhaler Treatment
NCT ID: NCT05213013
Last Updated: 2023-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
NA
64 participants
INTERVENTIONAL
2022-01-30
2023-01-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The research hypotheses are as follows:
H0: There is no significant difference between the intervention group and the the control group in the mean score of the "Child Fear Scale" and "Child Anxiety Scale-State" during and after the inhaler treatment with a toy-type nebulizer. H1: During and after the s inhaler treatment with the toy-type nebulizer, the mean score of the "Child Fear Scale" and "Child Anxiety Scale-State" is significantly higher in the intervention group compared to the control group.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of Distraction Methods Used During Inhalation Therapy on Children's Fear and Anxiety
NCT06510166
The Effect of Therapeutic Play Applied by Using Toy Nebulizer and Toy Mask on Child's Fear and Anxiety Level
NCT05415566
The Effects Of Toy In Chıldren Durıng Inhaler Therapy
NCT06924528
Active and Passive Distraction Techniques
NCT05242939
The Effect of Playing With a Toy Nebulizer and Watching Cartoons on the Fear and Anxiety on Children
NCT06339112
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Inhaler treatment will be applied to both the intervention and control groups. Both the parent and the child in the intervention group will be trained on the use of a nebulizer/mask. The children in the intervention group will be treated with a toy-type nebulizer and the group will be treated with an inhaler, and the control group will be given inhaler treatment with the standard nebulizer in the hospital. Two researchers were employed for the inhaler treatment both for the intervention and control groups. One researcher performed the inhaler treatment for all children and the other researcher helped the children to assess their fear and anxiety level. Fear and anxiety in children were evaluated by the children and their parents who before, during, and the procedure, and five minutes after the procedure. The inhaler treatment procedure was performed by the same researcher both in the intervention and control groups.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
HEALTH_SERVICES_RESEARCH
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Experimental
All registered participants in the control group, will receive inhaler treatment with the toy-type nebulizer in the hospital. Both the parent and the child in the intervention group will be trained on the use of a nebulizer/mask.
inhaler treatment with the toy-type nebulizer and training on on the use of a nebulizer/mask
The children (experimental group), will receive training and inhaler treatment with the toy-type nebulizer. The training topics is as follows:
* For effective nebulization, it should be ensured that the parts of the mask are assembled completely and correctly.
* The child should be in an upright sitting position during nebulization.
* During the procedure, normal breathing should be given into the mask.
* As the medicine is finished, a sizzling sound is heard from the device.
* After the nebula is over, the face should be washed and the mouth should be rinsed to remove the drug residues accumulated on the face and mouth.
No intervention
No intervention. All registered participants in the control group, will receive inhaler treatment with the standard nebulizer in the hospital. Both the parent and the child in the intervention group will not be trained on the use of a nebulizer/mask.
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
inhaler treatment with the toy-type nebulizer and training on on the use of a nebulizer/mask
The children (experimental group), will receive training and inhaler treatment with the toy-type nebulizer. The training topics is as follows:
* For effective nebulization, it should be ensured that the parts of the mask are assembled completely and correctly.
* The child should be in an upright sitting position during nebulization.
* During the procedure, normal breathing should be given into the mask.
* As the medicine is finished, a sizzling sound is heard from the device.
* After the nebula is over, the face should be washed and the mouth should be rinsed to remove the drug residues accumulated on the face and mouth.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* The child's application to the Pediatric Emergency Unit
* Child receiving inhaler treatment for the first time
* Parent and child agreeing to participate in the project
* Absence of speech and visual impairment of the child and his parents
Exclusion Criteria
* The child's application to another department except for the Pediatric Emergency Unit
* Child not receiving inhaler treatment for the first time
* Parent and child not agreeing to participate in the project
* Having speech and visual impairment of the child and his parents
4 Years
10 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Aylin Kurt
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Aylin Kurt
Principal Investigator
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Bartın University
Bartın, , Turkey (Türkiye)
Countries
Review the countries where the study has at least one active or historical site.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
2021-SBB-0333
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.